NYSE$NHC

National HealthCare Corporation · Q4 2022 earnings

Q4 2022 earnings · · Investor relations

Briefing

NHC's net income decreased due to reduced government stimulus income.

National HealthCare Corporation reported a decrease in net income for the quarter ended December 31, 2022, compared to the same period in 2021, primarily due to a reduction in government stimulus income. GAAP diluted earnings per share were $0.41, and adjusted diluted earnings per share were $0.72.

  • GAAP net income attributable to NHC was $6,353,000 for the quarter ended December 31, 2022, compared to $15,788,000 for the same period in 2021.
  • Adjusted net income for the quarter ended December 31, 2022, was $11,046,000, compared to $15,801,000 for the same period in 2021.
  • GAAP diluted earnings per share were $0.41 compared to $1.02 for the quarters ended December 31, 2022 and 2021, respectively.
  • Adjusted diluted earnings per share were $0.72 and $1.02 for the quarters ended December 31, 2022 and 2021, respectively.

Headline financials

Total Revenue

$265M

Previous: $283M-6.7%
EPS (adj)

$0.72

Previous: $1.02-29.4%
Capital Expenditures

$5.64M

Previous: $13.6M-58.6%
Free Cash Flow

$6.3M

Previous: $1.9M+231.8%
Net Income

$6.35M

Previous: $15.8M-59.8%
Operating Income

$0.00

Previous: $0.00
Gross Profit

$96.7M

Previous: $99.9M-3.3%
Cash & Equivalents

$58.7M

Previous: $108M-45.5%
Total Assets

$1.28B

Previous: $1.4B-9.1%
Stock-Based Comp

$632K

Previous: $715K-11.6%

Revenue & EPS history

NHC · Revenue · Quarterly

$265M

Q4 2022-6.7%vs Q4 2021

Revenue by segment

NHC · $260M total across 2 segments · Q1 2023

  • Net patient revenues
    $258M+2.8%
  • Other revenues
    $2.06M-87.5%

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2022

Historical avgQ4 2022

+0.1%

Avg return

Earnings day

+1.7%

Avg return

5 days after

+1.8%

Avg return

30 days after

60%

39 / 65 earnings

Positive

+12.2%

Q2 2023

Best reaction

-14.0%

Q4 2009

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.8%+11.8%+12.9%
Q4 2025+2.0%-4.7%-3.7%
Q3 2025+1.1%+3.4%+7.8%
Q1 2025+1.6%-3.1%-3.3%
Q4 2024+0.8%+0.1%-0.2%
Q3 2024+4.5%-0.1%-4.8%
Q2 2024+3.2%+3.7%+6.4%
Q1 2024+0.9%+4.4%+7.4%
Q4 2023+5.8%+7.1%-0.1%
Q3 2023+1.8%+3.9%+14.2%
Q2 2023+12.2%+12.6%+12.5%
Q1 2023+1.9%+5.4%+11.5%
Q4 2022-2.4%-3.9%-8.2%
Q3 2022-3.2%-1.0%-1.3%
Q2 2022+1.1%+1.9%+0.8%
Q1 2022+2.8%+0.8%+1.9%
Q4 2021+0.5%+0.4%+9.6%
Q3 2021+5.9%+1.3%-10.0%
Q2 2021-0.8%-2.4%-5.9%
Q1 2021-1.5%-1.6%+2.4%
Q4 2020+3.7%+10.3%+20.5%
Q3 2020-1.8%+13.0%+2.3%
Q2 2020+5.8%+5.0%-1.2%
Q1 2020-0.0%-5.0%+5.4%
Q4 2019-0.2%-8.4%-16.6%
Q3 2019-0.4%+0.1%+1.1%
Q2 2019-0.6%+0.4%-5.3%
Q1 2019+0.1%+1.4%+2.3%
Q4 2018+1.8%-0.2%-4.2%
Q3 2018-2.3%-3.5%-2.1%
Q2 2018+1.7%+4.4%+5.3%
Q1 2018+3.0%+3.8%+8.3%
Q4 2017-7.1%-2.5%-3.3%
Q3 2017-1.0%+2.9%+0.4%
Q2 2017+0.0%+2.3%-3.8%
Q1 2017-1.1%-1.2%-2.2%
Q4 2016+1.0%+0.8%+0.3%
Q3 2016-2.1%+1.0%+7.6%
Q2 2016+1.9%+2.6%+4.7%
Q1 2016-0.6%
Q4 2015-1.6%
Q3 2015+0.5%
Q2 2015-3.4%
Q1 2015+0.1%
Q4 2014+1.0%
Q3 2014+1.9%
Q2 2014+0.4%
Q1 2014+2.3%
Q4 2013-0.4%
Q3 2013+0.7%
Q2 2013+1.5%
Q1 2013-0.3%
Q4 2012+1.2%
Q3 2012+1.8%
Q2 2012-1.0%
Q1 2011-4.9%
Q1 2012+3.2%
Q4 2011-0.9%
Q3 2010+7.9%
Q3 2011+7.9%
Q4 2009-14.0%
Q4 2010-14.0%
Q2 2010-14.0%
Q2 2011-14.0%
Q1 2010+3.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro